Riskpilot← Back to searchSign inGet full accessMJN Fysioterapi i Norrköping AB
ABActiveOrg 5591199350Smedbygatan 23 BPhysiotherapy activities · NACE 8695Est. 20171 employees
Revenue 2025
SEK 1,6M
-4% vs 2024
EBITDA margin
8.5%
-62% vs 2024
Equity ratio
65.0%
Financial strength
Net profit 2025
SEK 114K
-62% vs 2024
| Revenue | SEK 1,6M | -4% |
| EBITDA | SEK 138K | -62% |
| Net profit | SEK 114K | -62% |
| Total assets | SEK 510K | -35% |
| Equity | SEK 331K | -36% |
| Employees | 1 | — |
Legal name
MJN Fysioterapi i Norrköping AB
Org number
5591199350
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
20 juli 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bistå med fysioterapi inom primärvården och därmed förenlig verksamhet i Norrköpings kommun. Detta i enlighet med samverkansavtal med Region Östergötland som gäller inom Norrköpings, Söderköpings och Valdemarsviks Kommun. Aktiebolaget kan även bistå med fysioterapi, friskvård och därmed förenlig verksamhet i kommuner, idrottsförbund och idrottsföreningar i hela Sverige samt handel av värdepapper
Address
Smedbygatan 23 B
Email
marianilsson21@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 146 | 1 124 | 1 708 | 1 675 | 1 611 |
| Staff expenses | — | −727 | −904 | −981 | −1 009 |
| EBITDA | 264 | 107 | 493 | 365 | 138 |
| Depreciation & amort. | −188 | −188 | — | — | — |
| EBIT | 76 | −81 | 493 | 365 | 138 |
| Net financials | −8 | −3 | −5 | 13 | 7 |
| Profit before tax | 51 | −24 | 388 | 378 | 145 |
| Tax | −11 | — | −76 | −78 | −31 |
| Net profit | 40 | −24 | 312 | 300 | 114 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 573 | 347 | 717 | 786 | 510 |
| Equity | 230 | 205 | 517 | 517 | 331 |
| Long-term debt | 230 | 106 | 0 | 0 | — |
| Short-term debt | 53 | 37 | 100 | 169 | 78 |
| Total debt | 283 | 142 | 100 | 169 | 78 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20212025
Equity ratio
65.0%
This company
38.2%
Market median
+70% vs market
20212025
Return on equity
34.5%
This company
18.4%
Market median
+88% vs market
20212025
Net profit margin
7.1%
This company
8.1%
Market median
-12% vs market
20212025
Asset turnover
3.16×
This company
1.12×
Market median
+182% vs market
20212025
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MJN Fysioterapi i Norrköping AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Josefina Nilsson | Chief Executive Officer | 0 companies |
| Martin Gustaf Bränge | Deputy Board Member | 0 companies |